Hybrid coronary revascularization versus total arterial revascularization for the treatment of left main coronary artery disease.

ABSTRACT:

Background

Hybrid coronary revascularization (HCR) has a similar clinical outcome to coronary artery bypass grafting (CABG) in treating multivessel disease. However, the outcome of HCR in treating left main coronary artery (LM) disease is unclear. This study sought to compare the clinical outcome of HCR with total arterial revascularization (TAR) for treating LM disease.

Methods

Patients who underwent treatment for LM disease in our center between January 2009 and December 2019 were selected. Of these, 33 patients underwent HCR, and 70 patients underwent TAR. The primary efficacy outcome of this study was mid-term major adverse cardiac and cerebrovascular events (MACCE). The primary safety outcome was perioperative MACCE.

Results

The incidence of postoperative outcome

SUBMITTER: Zhu P 

PROVIDER: S-EPMC7944322 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature